{"title":"右美沙芬:n -甲基-d-天冬氨酸受体拮抗剂治疗疼痛的研究进展","authors":"Anita Siu, Richard Drachtman","doi":"10.1111/j.1527-3458.2007.00006.x","DOIUrl":null,"url":null,"abstract":"<p>Dextromethorphan (DM) is a noncompetitive <i>N</i>-methyl-<span>d</span>-aspartate (NMDA) receptor antagonist, which is widely used as an antitussive agent. DM also prevents neuronal damage and modulates pain sensation via noncompetitive antagonism of excitatory amino acids (EAAs). DM has been found to be useful in the treatment of pain in cancer patients and in the treatment of methotrexate-induced neurotoxicity. Clinical studies with DM in cancer patients are reviewed in this article.</p>","PeriodicalId":94307,"journal":{"name":"CNS drug reviews","volume":"13 1","pages":"96-106"},"PeriodicalIF":0.0000,"publicationDate":"2007-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1527-3458.2007.00006.x","citationCount":"70","resultStr":"{\"title\":\"Dextromethorphan: A Review of N-methyl-d-aspartate Receptor Antagonist in the Management of Pain\",\"authors\":\"Anita Siu, Richard Drachtman\",\"doi\":\"10.1111/j.1527-3458.2007.00006.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Dextromethorphan (DM) is a noncompetitive <i>N</i>-methyl-<span>d</span>-aspartate (NMDA) receptor antagonist, which is widely used as an antitussive agent. DM also prevents neuronal damage and modulates pain sensation via noncompetitive antagonism of excitatory amino acids (EAAs). DM has been found to be useful in the treatment of pain in cancer patients and in the treatment of methotrexate-induced neurotoxicity. Clinical studies with DM in cancer patients are reviewed in this article.</p>\",\"PeriodicalId\":94307,\"journal\":{\"name\":\"CNS drug reviews\",\"volume\":\"13 1\",\"pages\":\"96-106\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-04-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1527-3458.2007.00006.x\",\"citationCount\":\"70\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CNS drug reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2007.00006.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS drug reviews","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2007.00006.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Dextromethorphan: A Review of N-methyl-d-aspartate Receptor Antagonist in the Management of Pain
Dextromethorphan (DM) is a noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist, which is widely used as an antitussive agent. DM also prevents neuronal damage and modulates pain sensation via noncompetitive antagonism of excitatory amino acids (EAAs). DM has been found to be useful in the treatment of pain in cancer patients and in the treatment of methotrexate-induced neurotoxicity. Clinical studies with DM in cancer patients are reviewed in this article.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
